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The purpose of this study was to assess the potential of
intraarterial ultrasound for in vivo recanalization of ath-
erosclerotic total occlusions. Ultrasound energy at a fre-
quency of 20 kHz was applied with a prototype solid wire
probe to 12 surgically implanted occluded human athero-
sclerotic arterial xenografts, 9 of which were calcified, as
well as to the intimal surface of 12 normal canine arteries.
In both the normal canine arteries and the atherosclerotic
occluded xenografts, there was no angiographic evidence of
vasospasm, thrombosis or arterial dissection.
Eleven of the 12 atherosclerotic complete arterial occlu-
sions were resistant to passage of a conventional guide wire
or probe without ultrasound energy. However, the occlu-
sions were recanalized after administration of 15 s to 4 ~!Jl
(mean 1.5 ± 1.3 min) of intermittent ultrasound energy.
After ultrasound, 8 of the 12 vessels underwent balloon
Because ultrasound is effective and safe for percutaneous
dissolution of genitourinary stones (1-4) and applications in
hepatic (5), neurologic (6) and cardiovascular surgery (7,8),
we hypothesized that this technology could be adapted to
intravascular use. In previous in vitro studies (9), we found
that catheter-delivered ultrasound energy could recanalize
human calcified and noncalcified atherosclerotic arterial
occlusions.
The goals ofthis study were to answer three questions: 1)
Can ultrasound recanalize atherosclerotic total arterial oc-
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angioplasty. Angiographic residual stenosis after ultra-
sound alone was 62 ± 24% and after combined ultrasound
and balloon angioplasty, 29 ± 13%. Although routine
angiography did not reveal arterial emboli, high resolution
cut films did demonstrate a few distal nonocclusive thrombi
of a size similar to that reported with other recanalization
methods. Histologic studies demonstrated changes similar
to those after balloon angioplasty, with focal cracking of the
fibrotic and calcified plaque.
The findings demonstrate that ultrasound energy ap-
plied through a catheter delivery system can be used in vivo
to open completely obstructed atherosclerotic vessels. These
studies suggest that it might be clinically feasible to use the
ultrasound probe to create a lumen, allowing subsequent
balloon dilation.
(J Am Coll Cardiol1990;15:345-51)
elusions in vivo? 2) Is ultrasound delivered by a probe and
catheter system traumatic to normal arterial intima? 3) What
are the major potential complications of ultrasound plaque
ablation in vivo?
Methods
The ultrasound device. We used a prototype device con-
structed to our specification (Blackstone Ultrasonics). Ultra-
sound frequency is fixed at 20 kHz and transmitted to target
areas by a ball-tipped Elgiloy (a cobalt-nickel alloy) wire
probe. The longitudinal and transverse amplitude of the
ultrasound probe is 50 ± 25 JLm. The acoustic power output
ranges from 25 to 50 W. The g forces at the probe tip range
from 0 to 82,000 g, varying as a direct function of the power
output in watts (9). The device operates in both a pulsed
(50% duty cycle of 20 ms) and a continuous mode. The
portable ultrasound generator is 115 V of alternating current
and weighs 7 kg. The l.5F to 2.6F solid wire probes range
0735-1097/90/$3.50
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Figure 1. Photograph of the prototype ultrasound device used for
arterial plaque ablation. The ultrasound generator (top) transmits
electrical energy to the ultrasound transducer, which is connected to
a ball-tipped wire probe ensheathed in an angiographic catheter
(bottom)
from 30 to 88 cm in length, are ball-tipped and are en-
sheathed in 7F to 9F catheters (Fig. 1). Normal saline
solution is infused through a guide catheter at a rate of 5
ml/min to prevent heating of the probe.
Normal arteries. Studies were performed in normal ca-
nine femoral arteries and in atherosclerotic human xe-
nografts to canine arteries (10). These studies conformed to
the Position of the American Heart Association on Research
Animal Use. Fifteen mongrel dogs weighing 25 to 35 kg were
anesthetized with sodium pentobarbital (30 mg/kg body
weight intravenously), intubated with a cuffed endotracheal
tube and ventilated. To determine if catheter-delivered ultra-
sound damages normal vascular intima, the probe was
applied to a 1 cm2 site in 12 normal canine femoral arteries.
The ultrasound probe was applied at 15 to 30 s intervals for
1to 6 min (mean 3.6 ± 1.6). The acoustic power output was
25 to 50 W (mean 37.5 ± 12.5). Six arteries received
continuous wave and six received pulsed wave ultrasound.
Arterial intimal damage was assessed by pre- and postpro-
cedure angiography and postmortem histologic examination.
Arteries were dissected for pathologic examination and
processed within 60 min of ultrasound recanalization. Arter-
ies were formalin-fixed, decalcified when necessary, serially
sectioned at 2 to 3 mm intervals at the site of ultrasound
application and processed routinely for histologic sectioning.
Five micron thick sections of all tissue samples were cut and
stained with hematoxylin-eosin. Selected sections were also
stained by Masson's trichrome and elastica van Gieson
stains.
Xenograft occlusions. We tested the ability of the ultra-
sound probe to recanalize guidewire-resistant atheroscle-
rotic obstructions. The criteria for selecting arteries for
implantation included: 1) total occlusion, 2) heavy calcifica-
tion (9 of 12 occlusions) or a tough (resistant to metal probe)
fibrous atherosclerotic occlusion, and 3) :::::2 cm length of the
completely occluded segment. We inspected autopsy and
amputation specimens over a 1year period, and retrieved 12
such totally occluded segments of human atherosclerotic
iliofemoral or popliteal arteries. These specimens were ob-
tained within 24 h of death or amputation. Because of the
limited supply of such occlusions and varying time intervals
to implantation, the arteries were stored in formalin for 1 to
60 days. The arteries were surgically implanted in canine
arteries (one carotid, two aortic, six iliac, three femoral).
Each specimen was classified as calcified (n = 9) or noncal-
cified (n = 3) by gross and histologic examination. Occlu-
sions were 2 to 7 cm in length. Eight dogs were given 5,000
U of heparin intravenously after implantation of the xe-
nografts. No dog was treated with aspirin.
Ultrasound angioplasty protocol. Angiography was per-
formed immediately before and after the ultrasound inter-
vention (n = 10) and again after balloon angioplasty (n = 8).
Only in one lesion was it possible to pass a conventional
0.035 in. (0.09 cm) Teflon-coated guide wire through the
obstructing lesion. In all other occlusions, attempts to pass a
guide wire across the lesions were unsuccessful. In the
remaining 11 obstructions, passage required energizing the
ultrasound probe. The ultrasound catheter was inserted
through a percutaneously placed introducer sheath in seven
cases and by surgical cutdown in five cases. In seven cases,
continuous wave and in five cases pulsed wave ultrasound
was used. The mean acoustic power output was 40 ± 13 W.
The intraarterial ultrasound recanalization performed
within 60 min of xenograft implantation was guided by
fluoroscopy and angiography. We used hand injections of a
50% dilution of Renografin (sodium diatrizoate) and saline
solution, injecting 10 ml/series. All 12 studies were recorded
on 0.75 in. videotape using images obtained from a fluoro-
scopic unit (Siemens Gigantos Cine Generator). Images are
recorded with a 525 line, 12 mega interlaced videocamera
(Adac Laboratories) and stored on a 0.75 in. (1.9 cm)
U-matic videotape recorder. The 7 in. (18 cm) image inten-
sifier yields a spatial resolution of 1.6 line pairs/mm. Four of
these studies were also recorded with 35 mm cine film at 30
frames/s at a dose of 35 microroentgen/frame and a spatial
resolution of 3 line pairs/mm. To further assess the potential
of distal arterial emboli, four other cases had cut film
angiography using a Franklin serial changer and supplemen-
tal single nonscreen films. (Nonscreen films provide approx-
imately six times the resolution of our screen films [11]). To
define the percent of arterial stenosis, the smallest luminal
diameter within the involved segment was measured with
calipers by two observers.
Postmortem histologic examination was performed on
the arterial segments exposed to the ultrasound probe.
Postmortem perfusion fixation was not used because the
arteries had been previously fixed in formalin. As for the
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normal arteries, the xenografts were serially sectioned at 2to
3 mm intervals and all tissue segments were embedded.
Thermal energy. To assess the amount of heat generated
during the application of ultrasound energy, the temperature
of the isolated ultrasound probe and of six ex vivo human
arterial segments was studied. The temperature of the probe
was monitored with an Agema thermal camera (model 782),
and the analysis was performed with an Agema thermal
analysis computer (model Te 800 Agema Infrared System).
The temperature of the blood vessels during continuous (n =
3) and pulsed wave (n = 3) ultrasound was monitored with
both the Agema thermal camera and thermal analysis com-
puter and a digital thermocoupler meter (model DP81-T,
Omega Engineering) incorporating a minihypodermic ther-
mocouple probe (HYP-O, Omega Engineering).
Results
Normal arteries. In the 12 normal canine arteries, ultra-
sound energy was delivered for an average of 3.6 ± 1.6 min
(range 1 to 6) of pulsed or continuous wave ultrasound.
There was no angiographic evidence of vasospasm, throm-
bosis or arterial dissection. Subsequent histologic examina-
tion of the arteries demonstrated intimal deposition of plate-
lets and fibrin in 1case and no histologic abnormalities in the
other 11 cases.
Ultrasound recanalization. Figure 2 shows the ultrasound
recanalization of a calcified and totally obstructed 4 em
human xenograft in a dog aorta. The retrograde aortogram
documents the complete occlusion of the human xenograft
(Fig. 2a). After 90 s of ultrasound ablation, the occlusion was
opened, and the vessel subsequently underwent balloon
dilation (Fig. 2b).
Figure 3a shows a baseline angiogram after surgical
insertion of bilateral external iliac atherosclerotic xenograft
occlusions. Both segments are completely occluded. Figure
3b shows the left external iliac artery residual stenosis after
60 s of ultrasound recanalization. Figure 3c demonstrates
opening of both external iliac arteries after ultrasound recan-
alization and subsequent balloon angioplasty of the left
external iliac artery. After recanalization of the external iliac
arteries, the internal iliac arteries (collateral vessels) became
less prominent.
All 12 completely occluded human atherosclerotic xe-
nografts, 9 ofwhich were calcified, were recanalized after 15
s to 4 min of intermittent ultrasound (mean 1.5 ± 1.3 min)
(Table 1). In the vessels with xenograft implants, there was
no angiographic evidence of ultrasound-induced vasospasm,
thrombosis or arterial dissection. After the ultrasound reca-
nalization, 8 of the 12 vessels underwent balloon angioplasty
to increase the arterial lumen area. Angiographic residual
stenosis of the complete occlusions with ultrasound recanal-
ization alone was 62 ± 24%; when ultrasound recanalization
was combined with balloon angioplasty, the residual stenosis
Figure 2. a, Retrograde aortogram in a canine model demonstrates a
4 cm xenograft occlusion (arrow) in the aorta. b, Catheter-delivered
ultrasound energy opened this occlusion. A small arterial dissection
(arrow) was created during subsequent balloon angioplasty to en-
large the arterial lumen.
was 29 ± 13% (Fig. 4). One vascular perforation occurred at
the xenograft distal anastomosis site in which the sutures
inadvertently obliterated the lumen and were severed during
the procedure. On the high resolution nonscreen angio-
grams, evidence of distal embolization was found in three
cases in which ultrasound recanalization was followed by
balloon angioplasty. The size of the emboli ranged from
500 to 2,000 }Lm. In all cases, the emboli were nonocclu-
sive.
Histology. Figure 5a shows an excised xenograft as it was
implanted into a dog femoral artery; the suture anastomosis
sites are evident at the proximal and distal ends of the
xenograft. Figure 5b shows a calcific iliac xenograft occlu-
sion in cross section; although the surface is somewhat
irregular, there is no evidence of severe intimal disrup-
tion.
Figure 6 shows the histologic appearance of an athero-
sclerotic calcified arterial occlusion after ultrasound recana-
lization. The intimal surface is slightly irregular, and a bar of
calcium is present across the top half of the lumen (Fig. 6a).
Focal cracking of the plaque and mild separation of the
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Figure 3. a, The baseline angiogram shows bilateral external iliac
atherosclerotic xenograft obstructions (arrows). The internal iliac
arteries appear prominent. b, Mter intraarterial ultrasound, ade-
quate patency (arrow) was achieved for subsequent balloon dilation
of the left external iliac artery. c, Intrarterial ultrasound energy
recanalized the right external iliac artery. No balloon angioplasty
was performed. With both vessels open, the internal iliac collateral
vessels are less prominent.
plaque from the media are evident. Figure 6b shows the
histologic appearance after concomitant balloon angioplasty.
Intimal disruption, cracking and fracture of fibrotic or calci-
fied plaques and focal separation of intimal plaques from
underlying media are evident. Intramural and adventitial
hemorrhage secondary to cracking and fracture of the plaque
was found in eight of the arteries.
Adverse effects. Nonocclusive thrombi were found in
histologic cross sections of the recanalized arterial xeno-
grafts in 5 of the 12 cases. In four of the five cases with
nonocclusive thrombi, both ultrasound and balloon angio-
plasty were performed. None of the native canine vessels or
human atherosclerotic xenografts had thermal damage or
vacuolation, degeneration or necrosis of smooth muscle cells
(12).
Table l. Ultrasound Probe Recanalization of 12 Atherosclerotic Total Occlusions
Residual Angiographic Stenosis (%)
Implant Site Duration of Power Ultrasound Combined Ultrasound
of Arterial Calcified Ultrasound Output Alone and Balloon Angioplasty
Case No. Xenograft Xenograft (min) (W) (n = 10) (n = 8)
I Femoral Yes 4.0 50 30
2 Femoral No 2.0 50 60
3 Femoral No 4.0 50 50
4 Carotid Yes 0.25 50 20
5 Aorta Yes 1.0 50 90 40
6 Aorta Yes 1.5 25 80 30
7 Iliac Yes 1.0 50 50
8 Iliac No 0.5 50 75 20
9 Iliac Yes 1.5 25 90 40
10 Iliac Yes 1.0 25 50 20
II Iliac Yes 0.5 25 20
12 Iliac Yes 1.0 25 75 15
Mean ± SD 1.5 ± 1.2 40 ± 13 62 ± 24 29 ± 13
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Figure 4. The angiographic residual stenosis after ultrasound abla-
tion without balloon angioplasty (n = 4) was 62 ± 24% (solid
squares). When ultrasound was followed by balloon angioplasty
(open circles at right), the residual stenosis was 29 ± 13%. In two of
the eight cases with combined ultrasound and balloon angioplasty,
angiograms were not available for the immediate postultrasound
study.
Discussion
In vivo study. This study is the first to document the
angiographic and histologic effects of ultrasound ablation
technology in normal and diseased vessels in vivo. In our
previous in vitro study (9), we demonstrated that catheter-
delivered ultrasound readily recanalizes total arterial occlu-
sions. In this in vivo study, we found that calcific arterial
obstructions do not impede ultrasound recanalization. Po-
tentially, the technique of ultrasound recanalization may be
best suited to calcific occlusions. Moreover, the power and
duration of ultrasound used for recanalization do not signif-
icantly damage normal vascular intima. The angiographic
residual stenosis using ultrasound without balloon angio-
plasty was 62 ± 24%. When ultrasound was followed by
balloon angioplasty, the residual stenosis was 29 ± 13%.
Furthermore, we found it feasible to use the ultrasound
probe to create a lumen and then increase the luminal area
with balloon dilation. Under the conditions we studied, a
guide wire tracking system was not required.
Biologic effects. The effects of surgical ultrasound on
tissues has been attributed to four factors: 1) mechanical
vibration, 2) cavitation, 3) thermal energy, and 4) the forma-
tion of intracellular microcurrents (4,6,7,13). We previously
hypothesized (9) that the primary mechanisms responsible
for ultrasound recanalization of atherosclerotic vessels are
the mechanical and cavitational effects. The mechanical
effect is due to the impact of the rapid (:;:::20,000 cycle/s)
movement of the probe on the rigid noncompliant portion of
tissues. We found (9) that compliant arterial segments are
unaffected by the probe's small amplitude of motion (50 ± 25
/Lm), whereas noncompliant diseased segments are dis-
rupted. This principle is employed in orthopedic cast cutters
and ultrasound dental units. Cavitational effects generate up
to 3 atm of pressure at the ultrasound probe tip. These
effects result from the creation and subsequent collapse of
Figure 5. a, An excised atherosclerotic human xenograft inserted
into a canine artery. The native canine vessel and suture anastomo-
ses are at the margins of the xenograft. b, The gross arterial cross
section shows the lumen created by the ultrasound angioplasty
probe in this calcified artery.
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Thermal energy. During the thermal studies, the ultra-
sound probe was cooled with normal saline solution at room
temperature (22°C). The total duration of exposure to ultra-
sound was 5 min for all six vessel segments, with the
ultrasound probe being applied in intervals of 30 s on and 15
s off. At baseline study, the temperature of the ultrasound
probe was 22°C, which increased to a maximum of 50°C after
5 min of continuous wave ultrasound. The temperature
increase in the ex vivo vessel segments was 50 ± 2°C after 5
min of continuous wave ultrasound and ::;30°C after pulse
wave ultrasound. The maximal temperature recorded within
the blood vessel wall by the thermocouple was 39°C during
continuous wave ultrasound. The lower temperatures re-
corded with the thermocouple compared with the thermal
camera may reflect focal cooling of the hypodermic thermo-
couple probe by the saline flush or placement of the record-
ing probe away from the site of maximal temperature in-
crease.
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Figure 6. a, Histologic section from an artery that had been totally
occluded by a calcified atherosclerotic plaque before in vivo ultra-
sound recanalization. A slightly irregular lumen (L) with a bar of
calcium (C) is present. Cracking of the plaque and mild focal
separation of the plaque from the media (asterisk) are present. b,
Histologic section from another artery that underwent balloon
angioplasty after in vivo ultrasound recanalization of the total
atherosclerotic occlusion. There are cracks in the plaque (arrows)
and focal separation of the plaque from the media (asterisk). There
is no thermal damage in either vessel (a, b, hematoxylin-eosin stain,
original magnification x20, reduced by 20%).
vapor-filled voids (bubbles) in fluids, cell and tissues (4,14-
18).
Potential adverse effects. Vascular perforation and arterial
wall damage have been associated with the use of most
catheter-delivered devices for ablating occlusive atheroscle-
rotic plaque (19-23). We found in our in vitro study (9) that
ultrasound also can cause thermal damage and vascular
perforation. In the present study, however, there was no
thermal or blast damage or ultrasound-induced perforation.
We believe there are several reasons for the reduction in
vascular damage in this study: 1) the probe was applied
coaxial to the arterial occlusion (not perpendicularly); 2)
cooling of the ultrasound probe was maintained by saline
infusion; 3) additional heat dissipation may have occurred
within the arterial blood; and 4) the delivered energy may
have been reduced by the loss of ultrasound energy around
bends. The precise amount of energy delivered at the abla-
tion site could not be measured. It was sufficient, however,
for recanalization of heavily calcified occlusions. In our
previous in vitro study (9), thermal damage and secondary
vascular perforation were associated with continuous wave
ultrasound, maximal power output of 50 Wand probe
application of >60 s. The continuous mode was used in
seven of the cases in this vivo study, without thermal
damage or perforation. Our present in vitro studies demon-
strate that cooling of the probe with saline solution, limiting
the application of the probe to ::;30 s and applying the probe
coaxially to the vessel do not result in the excessive gener-
ation of thermal energy (temperature ::;50 ± 2°C) as assessed
by direct temperature measurement and absence of his-
tologic evidence of thermal injury.
Embolization. This is an unresolved issue for all intravas-
cular ablation techniques. Routine angiography did not dem-
onstrate arterial emboli after ultrasound recanalization. High
resolution films, however, did reveal nonocclusive down-
stream debris. A limitation of this study is the use of
formalin-fixed rather than fresh human atherosclerotic ob-
structions. It is possible that formalin fixation may have
altered the embolic potential of the recanalized vessels. In
our previous in vitro study (9) of arteries stored in cold saline
solution, we found that 90% of the debris generated by
ultrasound plaque ablation is <25 JLm. Although our in vivo
study demonstrates generation of nonocclusive microem-
boli, no technique of recanalization, including balloon angio-
plasty (24-27), rotational (20) or drill devices (28) or laser
(29) is free of the potential for distal embolization. Prevosti
et al. (29) found that particulate debris >40 JLm was created
by both argon and excimer lasers. After guide wire manipu-
lation alone, we produced emboli of 2,000 JLm. Debris as
large as 2 cm has been found during atheroablation with the
Kensey catheter (20). With the Rotablator, a high speed drill
used for arterial recanalization, 5% of particulate debris is 41
to 250 JLm (28). When the calcific effluent generated by the
Rotablator is injected into a canine coronary artery, there is
a 50% to 100% reduction in blood flow (30). Because the
emboli in the present study were detected only with high
resolution filming and because most of the ablation tech-
niques have been used successfully in human patients, this
size and number of emboli are probably not of clinical
significance in peripheral arteries.
Conclusions. The results of this study demonstrate that
ultrasound delivered through a catheter guidance system can
be used to rapidly open completely obstructed atheroscle-
rotic vessels. As a result of the use of surgically implanted
formalin-fixed xenografts, direct extrapolation of these re-
sults to native arterial occlusions may be limited. In our
JACC Vol. 15, No.2
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view, the next steps in the development of this technology
are to assess the long-term effects of ultrasound ablation on
the normal and atherosclerotic arterial wall and to develop a
prototype system for testing in peripheral vessels in humans.
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